These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12496989)

  • 21. Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer.
    Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P
    Urology; 2004 Apr; 63(4):751-6. PubMed ID: 15072894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment options for prostate cancer: evaluating the evidence.
    Bhatnagar V; Kaplan RM
    Am Fam Physician; 2005 May; 71(10):1915-22. PubMed ID: 15926407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Practical management of localized prostate cancer: surveillance, surgery or radiotherapy].
    Le Duc A
    Rev Prat; 1994 Mar; 44(5):591-3. PubMed ID: 8066395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do older men benefit from curative therapy of localized prostate cancer?
    Alibhai SM; Naglie G; Nam R; Trachtenberg J; Krahn MD
    J Clin Oncol; 2003 Sep; 21(17):3318-27. PubMed ID: 12947068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Practice guideline 'Prostate cancer: diagnosis and treatment'].
    de Reijke TM; Battermann JJ; van Moorselaar RJ; de Jong IJ; Visser AP; Burgers JS
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1771-5. PubMed ID: 18754308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of clinically localized prostate cancer by radical prostatectomy followed by watchful waiting.
    Kirby R
    Nat Clin Pract Urol; 2005 Jun; 2(6):298-303. PubMed ID: 16474812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What's a man to do? Treatment options for localized prostate cancer.
    Pickles T
    Can Fam Physician; 2004 Jan; 50():65-72. PubMed ID: 14761106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM; Porter MP; Soloway MS
    J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PSA relapse prostate cancer: the importance of tailored therapy.
    Aranha O; Vaishampayan U
    Urol Oncol; 2004; 22(1):62-9. PubMed ID: 14969807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation therapy after radical prostatectomy: a review of the issues and options.
    Valicenti RK; Gomella LG; Perez CA
    Semin Radiat Oncol; 2003 Apr; 13(2):130-40. PubMed ID: 12728442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term results of adjuvant hormonal therapy plus radiotherapy following radical prostatectomy for patients with pT3N0 or pT3N1 prostate cancer.
    Miyake H; Sakai I; Harada K; Hara I; Eto H
    Int J Urol; 2004 Jun; 11(6):397-401. PubMed ID: 15157209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment choice and quality of care for men with localized prostate cancer.
    Miller DC; Spencer BA; Ritchey J; Stewart AK; Dunn RL; Sandler HM; Wei JT; Litwin MS
    Med Care; 2007 May; 45(5):401-9. PubMed ID: 17446826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient treatment preferences in localized prostate carcinoma: The influence of emotion, misconception, and anecdote.
    Denberg TD; Melhado TV; Steiner JF
    Cancer; 2006 Aug; 107(3):620-30. PubMed ID: 16802287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initial treatment patterns for clinically localized prostate cancer and factors associated with the treatment in Louisiana.
    Wu X; Chen VW; Andrews PA; Chen L; Ahmed MN; Schmidit B; Hsieh M; Fontham ET
    J La State Med Soc; 2005; 157(4):188-94. PubMed ID: 16250368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life outcomes following treatment for localized prostate cancer: is there a clear winner?
    Parker WR; Montgomery JS; Wood DP
    Curr Opin Urol; 2009 May; 19(3):303-8. PubMed ID: 19300266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health-related quality of life in Japanese men with localized prostate cancer: assessment with the SF-8.
    Sugimoto M; Takegami M; Suzukamo Y; Fukuhara S; Kakehi Y
    Int J Urol; 2008 Jun; 15(6):524-8. PubMed ID: 18422571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbidity and primary treatment for localized prostate cancer: data from CaPSURE.
    Marr PL; Elkin EP; Arredondo SA; Broering JM; DuChane J; Carroll PR
    J Urol; 2006 Apr; 175(4):1326-31. PubMed ID: 16515991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation and management of prostate-specific antigen recurrence after radical prostatectomy for localized prostate cancer.
    Naito S
    Jpn J Clin Oncol; 2005 Jul; 35(7):365-74. PubMed ID: 15976063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A retrospective study of the treatment of locally advanced prostate cancer by six institutions in eastern and north-eastern Japan.
    Hachiya T; Akakura K; Saito S; Shinohara N; Sato K; Harada M; Kato T; Okada K
    BJU Int; 2005 Mar; 95(4):534-40. PubMed ID: 15705075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Localized cancer of the prostate: which treatment should be chosen?].
    Jayet C; Leisinger HJ
    Rev Med Suisse Romande; 2003 Mar; 123(3):191-4. PubMed ID: 15095706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.